NCT02014662View on ClinicalTrials.gov

A Methodology Study to Assess Muscle Damage After Eccentric Exercise

PHASE1CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

January 14, 2014

Primary Completion Date

July 2, 2014

Study Completion Date

July 2, 2014

Conditions
Tendon Injuries
Interventions
OTHER

Eccentric exercise

Each subject will perform eccentric exercise against a predefined personal maximal strength of their non-dominant leg on day 1. Changes on strength, biomarker concentrations and muscle protein synthesis during damage and recovery will be measured over 22 days.

Trial Locations (1)

NG7 2UH

GSK Investigational Site, Nottingham

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY

NCT02014662 - A Methodology Study to Assess Muscle Damage After Eccentric Exercise | Biotech Hunter | Biotech Hunter